Related Experiment Video
Updated: Nov 5, 2025

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
Published on: August 30, 2019
Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
Erez N Baruch1,2, Jingjing Wang3, Jennifer A Wargo2,4
1Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas. jwargo@mdanderson.org ENBaruch@mdanderson.org.
Abstract:
Several landmark preclinical studies have shown an association between the gut microbiota and the effectiveness of immunotherapy for cancer. These studies have sparked clinical trials aimed at modulating the gut microbiota in order to improve clinical response rates to immunotherapy. Despite this, the mechanisms through which the gut microbiota influences the effectiveness of immunotherapy are still incompletely characterized. Preclinical and preliminary clinical findings from numerous types of gut microbiota modulation studies, including fecal transplantation, probiotics, consortia, and diet, demonstrate that favorable microbiota modulation is associated with increased intratumoral infiltration of CD8+ effector T cells. This CD8+ T-cell infiltration is often associated with enhanced intratumoral activity of T-helper type 1 cells and dendritic cells and a lower density of immunosuppressive cells. Herein, we discuss how gut microbiota may affect the activity of immune cells by at least three interlacing mechanisms: activation of pattern recognition receptors, molecular mimicry, and impact of metabolites. We also discuss the therapeutic potential and limitations of the different gut microbiota modulation techniques and their putative mechanisms of immune activation.
Insights
The gut microbiota influences cancer immunotherapy effectiveness by modulating immune cell activity. Strategies like fecal transplants and probiotics aim to enhance anti-cancer immune responses.
Area of Science:
- Immunology
- Microbiology
- Oncology
Background:
- Preclinical studies link gut microbiota composition to cancer immunotherapy efficacy.
- Clinical trials are exploring microbiota modulation to improve treatment outcomes.
- Mechanisms underlying microbiota's influence on immunotherapy remain incompletely understood.
Purpose of the Study:
- To review the mechanisms by which gut microbiota impacts immunotherapy effectiveness.
- To discuss various gut microbiota modulation strategies and their therapeutic potential.
- To explore the immune activation pathways involved.
Main Methods:
- Review of preclinical and clinical findings on gut microbiota modulation.
- Analysis of studies involving fecal transplantation, probiotics, consortia, and diet.
- Discussion of proposed immune activation mechanisms.
Main Results:
- Favorable gut microbiota modulation correlates with increased CD8+ T cell infiltration into tumors.
- Enhanced microbiota is associated with increased T-helper type 1 cell and dendritic cell activity.
- Microbiota modulation can lead to a reduction in immunosuppressive cells within the tumor microenvironment.
Conclusions:
- Gut microbiota influences immunotherapy by activating pattern recognition receptors, molecular mimicry, and metabolite production.
- Various modulation techniques show therapeutic potential but have limitations.
- Understanding these mechanisms is crucial for optimizing cancer immunotherapy.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

